Cargando…

Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry

AIMS : Cardiac magnetic resonance (CMR) is recommended in the diagnosis of cardiomyopathies, but it is time-consuming, expensive, and limited in availability in some European regions. The aim of this study was to determine the use of CMR in cardiomyopathy patients enrolled into the European Society...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizia-Stec, Katarzyna, Charron, Philippe, Gimeno Blanes, Juan Ramon, Elliott, Perry, Kaski, Juan Pablo, Maggioni, Aldo P, Tavazzi, Luigi, Tendera, Michał, Felix, Stephan B, Dominguez, Fernando, Ojrzynska, Natalia, Losi, Maria-Angela, Limongelli, Giuseppe, Barriales-Villa, Roberto, Seferovic, Petar M, Biagini, Elena, Wybraniec, Maciej, Laroche, Cecile, Caforio, Alida L P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219354/ https://www.ncbi.nlm.nih.gov/pubmed/33417664 http://dx.doi.org/10.1093/ehjci/jeaa329

Ejemplares similares

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
por: Asselbergs, Folkert W., et al.
Publicado: (2020)

ESC EORP Cardiomyopathy Registry: real‐life practice of genetic counselling and testing in adult cardiomyopathy patients
por: Heliö, Tiina, et al.
Publicado: (2020)

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
por: Lopes, Luis R, et al.
Publicado: (2022)

Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry
por: Jackson, Alice M., et al.
Publicado: (2021)

Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry
por: Mbakwem, Amam C., et al.
Publicado: (2021)

Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology
por: Mizia‐Stec, Katarzyna, et al.
Publicado: (2020)

Corrigendum to: Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry
Publicado: (2021)

Editorial: Paediatric Cardiomyopathies
por: Monda, Emanuele, et al.
Publicado: (2021)

AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation
por: Saglietto, Andrea, et al.
Publicado: (2022)

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy
por: Monda, Emanuele, et al.
Publicado: (2023)

Hypertensive disorders of pregnant women with heart disease: the ESC EORP ROPAC Registry( )
por: Ramlakhan, Karishma P, et al.
Publicado: (2022)

Adenosine usage during AF ablation in Europe and selected long-term findings from the ESC-EHRA EORP Atrial Fibrillation Ablation Long-Term registry
por: van Rosmalen, Frank, et al.
Publicado: (2020)

Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
por: Kong, William K F, et al.
Publicado: (2022)

Electrocardiographic Screening of Arrhythmogenic Cardiomyopathy in Genotype-Positive and Phenotype-Negative Relatives
por: Lopez-Ayala, Jose Maria, et al.
Publicado: (2021)

Evaluation of the pharmacotherapeutic impact on contractility recovery in patients with newly diagnosed, acute onset dilated cardiomyopathy
por: Orszulak, Michal, et al.
Publicado: (2023)

Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry
por: Donal, Erwan, et al.
Publicado: (2023)

Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
por: Ding, Wern Yew, et al.
Publicado: (2022)

Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
por: Kapelios, Chris J, et al.
Publicado: (2023)

Infective endocarditis in the Netherlands: current epidemiological profile and mortality: An analysis based on partial ESC EORP collected data
por: El Kadi, S., et al.
Publicado: (2020)

Corrigendum to: Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
Publicado: (2023)

Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)
por: Tutarel, Oktay, et al.
Publicado: (2022)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry
por: Bohbot, Yohann, et al.
Publicado: (2022)

Storage diseases with hypertrophic cardiomyopathy phenotype
por: Ruiz-Guerrero, Luis, et al.
Publicado: (2018)

Prediction of thrombo‐embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk‐CVA)
por: Guttmann, Oliver P., et al.
Publicado: (2015)

Functional Mitral Regurgitation in Patients with Preserved Ejection Fraction Qualified for Pulmonary Vein Isolation: A Negative Prognostic Factor for Catheter Ablation Efficacy
por: Cichoń, Małgorzata, et al.
Publicado: (2021)

Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
por: Bula, Karolina, et al.
Publicado: (2022)

Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
por: Soler, Rafaela, et al.
Publicado: (2018)

Alcohol septal ablation in hypertrophic cardiomyopathy
por: Mateo, Juan José Santos, et al.
Publicado: (2018)

ARNI in HFrEF—One-Centre Experience in the Era before the 2021 ESC HF Recommendations
por: Niemiec, Rafał, et al.
Publicado: (2022)

New ESC guidelines on hypertrophic cardiomyopathy: new insights in invasive treatment?
por: van der Wall, E. E.
Publicado: (2014)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
por: Stec, Maria, et al.
Publicado: (2023)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Transcatheter aortic valve implantation in moderate bicuspid aortic valve disease in a patient with end-stage dilated cardiomyopathy – bridge to heart transplantation
por: Mizia-Szubryt, Magdalena, et al.
Publicado: (2021)

Atorvastatin facilitates protection against contrast-induced nephropathy in patients undergoing coronary angiography via humoral mediators rather than altered renal hemodynamics
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Heart Failure with Improved Ejection Fraction: Insight into the Variable Nature of Left Ventricular Systolic Function
por: Wybraniec, Maciej T., et al.
Publicado: (2022)

Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
por: Monda, Emanuele, et al.
Publicado: (2022)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography
por: Wybraniec, Maciej T., et al.
Publicado: (2016)

Clinical and Genetic Screening for Hypertrophic Cardiomyopathy in Paediatric Relatives: Changing Paradigms in Clinical Practice
por: Lawley, Claire M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mdoeu6o3n6ms6h4ga432vvpj6e